Ipsen has acquired Sterix Limited, a UK-based company that specializes in the research and development of a new generation of steroid-based therapeutic products for use in oncology and metabolism or endocrine-related diseases.
Sterix, a spin-out from the University of Bath and Imperial College, was sold to Ipsen Group, a European specialist pharmaceutical company, in 2004.
Sterix specializes in the research and development of a new generation of steroid-based therapeutic products for use in oncology and metabolism or endocrine-related diseases, including cancer treatments, women's health, diabetes and hormone-associated diseases. The acquisition allowed Ipsen to reinforce its pipeline in the field of oncology and build upon the innovative work carried out by Sterix.
Download the vector logo of the Sterix Limited brand designed by in Adobe® Illustrator® format. The current status of the logo is active, which means the logo is currently in use.
- J.J. Paul
- Vector format:
- Active Report as obsolete
- Vector Quality:
- No ratings
- Updated on:
- Tue, 08/03/2010 - 01:05